MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldomet 500mg tablets (Aspen Pharma Trading Ltd) and Methyldopa 500mg tablets (Sovereign Medical Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldomet 500mg tablets (Aspen Pharma Trading Ltd) and Methyldopa 500mg tablets (Sovereign Medical Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldomet 500mg tablets (Aspen Pharma Trading Ltd) and Methyldopa 500mg tablets (Sovereign Medical Ltd).

Stability Notes

Store in air-tight containers. Protect from light and moisture. Maximum 28 days in a MCA

Provenance

Compatibility information derived from Metoprolol 100mg tablets (Accord Healthcare Ltd).

Stability Notes

Store in tight, light-resistant containers.

Provenance

This compatibility recommendation is derived from Aldomet 500mg tablets (Aspen Pharma Trading Ltd) and Methyldopa 500mg tablets (Sovereign Medical Ltd).

Stability Notes

No special requirements for storage.

Provenance

Compatibility recommendation derived from Physiotens 200microgram tablets (Viatris UK Healthcare Ltd).

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Ismo 10 tablets (Esteve Pharmaceuticals Ltd).

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Ismo 10 tablets (Esteve Pharmaceuticals Ltd).

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Ismo 10 tablets (Esteve Pharmaceuticals Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.